StudyFinder

Search Results Within Category "Prevention & Wellness"

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories
8 Study Matches

Dissecting the role of acetaldehyde in oral carcinogenesis

The goal of this study is to better understand how drinking alcohol may lead to oral cancers. Acetaldehyde, a chemical formed when the body breaks down alcohol, is believed to play an important role. This study will measure acetaldehyde and DNA damage levels in the mouth of participants after a low dose of alcohol. The levels will be compared between three groups, all having different degrees of risk for developing oral cancer, in order to identify DNA damage that might be crucial to cancer formation.

Recruiting

Alcohol Study - alcohol-study@umn.edu

Silvia Balbo
18 years and over
NA
This study is also accepting healthy volunteers
33324
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• 21 to 45 years of age alcohol drinker
• Experiences flushing (reddening or warming of face) when you drink OR have Fanconi Anemia
• 18 to 45 years of age non-drinkers
Exclusion Criteria:

• Tobacco or nicotine users
Prevention & Wellness
Alcohol, drinking, Fanconi Anemia
I'm interested
Share via email
See this study on ClinicalTrials.gov

The effects of cigarette smoking and alcohol on DNA damage in the oral cavity

The purpose of this study to examine the effects of cigarette smoking and drinking alcohol on the formation of DNA damage in the mouth. The overall goal is to identify DNA damage that may be important to the development of cancer.

Recruiting

Laura Garcia Pimentel - garci970@umn.edu

Stephen Hecht, PhD
18 years and over
This study is also accepting healthy volunteers
36605
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• Daily cigarette smoker
• 21 years of age or older
• Non-drinkers and alcohol drinkers
Prevention & Wellness, Cancer
alcohol, cigarettes, drinking, Smoking, tobacco
I'm interested
Share via email

Biomarkers of Exposure and Effect in SREC Users

The purpose of this study is to better understand how switching from smoking to the use of electronic cigarettes (e-cigarettes) may change users’ exposures to various harmful chemicals. Your participation will also help us to understand how nicotine that is present in e-cigarettes is taken in and modified by your body.

Recruiting

Andrew Egbert - egber014@umn.edu

Irina Stepanov
18 years and over
PHASE1
This study is also accepting healthy volunteers
20589
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
* Male or female smokers who are 18-65 years of age and are willing to stop smoking and completely switch to e-cigarettes or medicinal nicotine; * Report smoking ≥ 5 cigarettes daily and not using any other nicotine or tobacco product; * Biochemically confirmed regular smoking status by a NicAlert test level of 6; * Smoking daily for at least 1 year and no serious quit attempts (e.g., quit for 24 hours or longer) in the last 3 months (to ensure stability of daily smoking, particularly for those randomized to the continued smoking group); * No unstable and significant medical or psychiatric conditions as determined by medical history and Prime-MD (to ensure safety of the subject, to minimize the effects of poor health on biomarker measures and to maximize compliance to study procedures); * Subjects are in good physical health (no unstable medical condition); * Subjects are in stable, good mental health (e.g. not currently, within the past 6 months, experiencing unstable or untreated psychiatric diagnosis, including substance abuse); * Subjects who are not taking anti-inflammatory medications or any medications that affect relevant metabolic enzymes; * Women who are not pregnant or nursing or planning to become pregnant; * Subject has provided written informed consent to participate in the study (adolescents under the age of 18 will be excluded because this project involves continued use of tobacco products and new tobacco products).
Exclusion Criteria:
* Regular tobacco or nicotine product use (e.g., 9 days in last 30 days) other than cigarettes; * Currently using nicotine replacement or other tobacco cessation products; * Significant immune system disorders, respiratory diseases, kidney or liver diseases or any other medical disorders that may affect biomarker data; * Unstable health conditions (any significant serious, unstable medical condition including, but not limited to, cardiovascular disease, unstable COPD, seizure disorder and cancer, as determined by the licensed medical professional); * Unstable mental health (to be determined by medical history, CESD, Prime-MD after review by the licensed medical professional); * Excessive drinking (e.g., 5 or more drinks daily) or problems with drinking or drugs (e.g., self-report of binge drinking alcohol or treatment for drug or alcohol abuse within last 3 months); to be assessed by PI or licensed medical professional; * Blood alcohol test \> 0.01 (g/dL) as measured by a breath sample at screening (participants failing the breath alcohol screen will be allowed to re-screen once; * Positive toxicology screen for any of the following drugs: cocaine, opiates, methadone, benzodiazepines, barbiturates, amphetamines, methamphetamines, and PCP. Failing temperature strip for the sample. Marijuana will be tested for, but will not be an exclusionary criterion. Participants with valid prescriptions for opiates, benzodiazepines, barbiturates, amphetamines or methadone will not be excluded. Participants failing the toxicology screen will be allowed to re-screen once; * Pregnant or breastfeeding; * Failure to agree to take adequate protection to avoid becoming pregnant during the study; * Vital signs outside of the following range (participants failing for vital signs will be allowed to re-screen once): * Systolic BP greater than or equal to 160 mm/hg * Diastolic BP greater than or equal to 100 mm/hg * Systolic BP below 90 mm/hg and symptomatic (dizziness, extreme fatigue, difficulty thinking, inability to stand or walk, feeling faint) * Diastolic BP below 50 mm/hg and symptomatic (dizziness, extreme fatigue, difficulty thinking, inability to stand or walk, feeling faint) * Heart rate greater than or equal to 105 bpm * Heart rate lower than 45 bpm and symptomatic (dizziness, extreme fatigue, difficulty thinking, inability to stand or walk, feeling faint) * Expired air carbon monoxide (CO) level greater than 80 ppm; * Self-reported allergies to propylene glycol or vegetable glycerin; * Adverse reactions when previously using electronic cigarettes; * Household member enrolled in the study concurrently; * Unable to read for comprehension or completion of study documents; * Unstable living environment that would compromise the ability to attend visits, sequester study products or complete study procedures outside of visits.
Prevention & Wellness
I'm interested
Share via email
See this study on ClinicalTrials.gov

Profiling of Adipose Tissue Depots and Immune Correlates

This is a study of individuals older than 18, undergoing abdominal surgery, and are amenable to fat samples being collected during their surgical procedure, with the option to participate in other tests that can provide information on insulin sensitivity and fat distribution. This study is trying to figure out how fat tissue is related to an individual's health status and health conditions, and the analysis of the aging of cells that make up the human body.

Recruiting

Allison Wolf - wolfx494@umn.edu

Sayeed Ikramuddin
18 years and over
This study is NOT accepting healthy volunteers
29035
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• Age 18 years or older
• Undergoing abdominal surgical procedure with general anesthesia
Exclusion Criteria:

• Pregnancy or nursing
• Exclusion at the discretion of attending physician or Eligibility Committee
Diabetes & Endocrine, Digestive & Liver Health, Prevention & Wellness
abdominal surgery, fat collection
I'm interested
Share via email

Ten Thousand Families Study

The purpose of this study is to study the evolution of early life risk factors that may lead to cancer and other conditions. This is a prospective cohort study of families who reside in Minnesota.

Recruiting

Clemen Wilcox - clemenw@umn.edu

Jen Poynter
Not specified
This study is also accepting healthy volunteers
20212
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• 1st Participant: 18+ living in MN
• Other family members: All ages and must live in MN, ND, SD, IA, or WI
• Participants ages 0-17 must have a parent consent to their participation and assist with study activities
Exclusion Criteria:

• Unwilling or unable to provide DNA and blood sample
• Does not have at least 1 living family member in MN IA, ND, SD, or WI
Cancer, Microbiota, Prevention & Wellness
10KFS, environment, exposures, family, genetics, glyphosate, lifestyle, Minnesota, PFAS, radon
I'm interested
Share via email

Targeting Family Meal Quality and Quantity to Reduce Childhood Obesity Using Ecological Momentary Intervention (EMI) and Video Feedback

The proposed study is an individual three-arm randomized controlled tiled aimed at utilizing state-of-the-art intervention methods to examine whether increasing the quality and the quantity of family meals reduces childhood obesity.

Recruiting

Marah Aqeel - aqeel002@umn.edu

Jerica Berge
Up to 18 years old
NA
This study is also accepting healthy volunteers
20261
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• Child 5-10 years old
• Have a sibling who lives in the home with the child
• Live in the Metro area
• Speaks English or Spanish
Children's Health, Prevention & Wellness
family, family meals, nutrition, primary care
I'm interested
Share via email
See this study on ClinicalTrials.gov

Stress Response and Opioid Dysfunction in Nicotine Dependence

This study includes healthy adults between 18-70 years old who are either non-smokers or cigarette smokers interested in quitting. The purpose of this study is to learn more about how people respond to stress and to taking one dose of a widely and safely used drug called naltrexone as well as to learn about how these responses relate to whether or not someone smokes, smoking cessation, and smoking relapse.

Recruiting

Behavioral Medicine Laboratories - bml-tc@d.umn.edu

Mustafa al'Absi
18 years and over
This study is NOT accepting healthy volunteers
27656
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• Live in Minnesota.
• Between 18-70 years old.
• Generally healthy.
• Want to quit using tobacco and nicotine.
• Are willing to attend up to 11 online (videoconference) study visits over a period of approximately 4 months (though you may be asked to complete the last visits over a period of up to 1 year).
Exclusion Criteria:

• Do not live in Minnesota.
• Not between 18-70 years old.
• Not willing to attend to up to 11 online (videoconference) study visits over a period of approximately 4 months.
Heart & Vascular, Mental Health & Addiction, Prevention & Wellness
cigarette, nicotine, quit smoking, smoker, smoking, smoking cessation, stress, tobacco
I'm interested
Share via email

Methodology and Development of Tobacco Related Biomarkers Methodology and Development of Tobacco Related Biomarkers, part of 'Metabolism of Carcinogenic Tobacco-Specific Nitrosamines'

The purpose of this study is to better understand how tobacco and nicotine products affect our bodies. In this observational study smokers, vapers, smokeless tobacco users, nicotine replacement product users, non-users, and ex-users will be asked to provide biological samples. We will look for biological “markers” (biomarkers), or chemical changes in the body, that occur due to tobacco or nicotine exposure. Collected samples will be used for the development of biomarkers of toxicant exposure and for assessing exposure between the different groups. The intent is to eventually use these biomarkers to improve detection, prevention, and treatment strategies for tobacco-related diseases. This study will allow us to test currently used biomarkers, and to establish a biorepository (sample bank) to identify and develop new biomarkers associated with tobacco exposure and cessation. The type of samples and amount collected will depend on the specific biomarker(s) being developed or tested. Potential samples include saliva, cheek (buccal) & oral cells, blood, urine, hair, and/or nail clippings.

Recruiting

Laura Garcia Pimentel - garci970@umn.edu

Stephen Hecht, PhD
18 years and over
This study is also accepting healthy volunteers
11095
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:

• 21 years or older
• Daily user of tobacco or nicotine products
Exclusion Criteria:

• Unstable health condition
• Pregnant or nursing
Cancer, Community Health, Prevention & Wellness
nicotine, nicotine replacement, smokeless tobacco, smoker, smoking, tobacco, vaper, vaping
I'm interested
Share via email